Navigation Links
Decision Resources' Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
Date:8/17/2010

WALTHAM, Mass., Aug. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, will host the Competitive Landscape Seminar Series: Biologics and Biosimilars, a one-day seminar addressing current and future trends in the biologics and biosimilars markets on September 14, 2010. The seminar will include presentations on a range of industry and therapeutic-specific topics, and will help pharmaceutical companies understand market opportunities for biologics and biosimilars.

The seminar will be held in New York, N.Y. on September 14, 2010 and will answer the following questions:

  • Who are the key players in the biologics market and who will see the greatest growth?
  • Which companies are in the best position to produce biosimilars?
  • How quickly will biologics saturate niche markets?
  • What are the current and future prospects for biologics in the emerging markets?
  • How are payers influencing the biologics market in the United States?
  • What opportunities and challenges lie ahead for agents in specific therapeutic areas such as immune and oncology?

  • "Developments in the biologics and biosimilars markets are constantly evolving and present significant opportunities, as well as potential challenges, for pharmaceutical manufacturers," said Decision Resources Chief Operating Officer Jason LaBonte. "This high-value seminar is geared toward both manufacturers already operating in the biologics and biosimilars markets, as well as companies exploring market opportunities in this space. Attendees will leave with an understanding of the current trends in biologics and biosimilars and how these trends will shape future opportunities."

    Presentation topics include:

  • What Opportunity Remains for Emerging and Novel Immune-Targeted Agents in a TNF-Dominated World?
  • Processes and Paradigms: Which Companies Can Actually Produce Biosimilars and How?
  • Monoclonal Antibodies and the Transformation of the Oncology Landscape
  • First-Launch Small Molecule Therapies and Biologic Agents: Challenges and Opportunities Facing Novel Types of Therapies Entering New Markets
  • Moving Beyond the Major Markets: Current and Future Prospects for Biologics in the Emerging Markets

  • For more information about registration and to view the meeting agenda, please visit: http://www.competitivelandscapeseries.com/biologics-and-biosimilars/.

    Media InvitationMembers of the media interested in receiving an invitation to the Decision Resources' Competitive Landscape Seminar Series: Biologics and Biosimilars should contact Lisa Osgood at 781-296-2606 or by e-mail at losgood@hl-isy.com.

    About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

    About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

    All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Decision ResourcesDecision Resources, Inc.Lisa Osgood

    Christopher Comfort781-296-2606

    781-296-2597 losgood@hl-isy.com

    ccomfort@dresources.com
    '/>"/>

    SOURCE Decision Resources
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. FDA Issues Assessments of the 510(k) Program and Use of Science in Decision-Making
    2. Medco CEO to Present at the Sanford C. Bernstein & Co., LLC 26th Annual Strategic Decisions Conference 2010
    3. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
    4. HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures
    5. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
    6. Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions
    7. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
    8. Enbrel Will Remain Decision Resources Clinical Gold Standard Through 2018 for the Treatment of Rheumatoid Arthritis
    9. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
    10. Hologic Announces Decision in Patent Infringement Suit
    11. Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping Unreasonable, Unfair and Discriminatory
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/11/2017)... Calif. , Oct. 11, 2017  BioPharmX Corporation ... scientific team that developed an innovative way to use ... of the delivery of new drugs. ... Fall Clinical Dermatology Conference will show how researchers from ... Hospital, Harvard Medical School used a suite of imaging ...
    (Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
    (Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
    (Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
    (Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
    (Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
    (Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
    Breaking Medicine News(10 mins):